Wattmo, Carina

Mild cognitive impairment and deficits in instrumental activities of daily living: A systematic review

Jekel, K., Damian, M., Wattmo, C., Hausner, L., Bullock, R., Connelly, P. J., Dubois, B., Eriksdotter, M., Ewers, M., Graessel, E., et al. (2015) · Alzheimer's Research & Therapy

Dementia and Cognitive Impairment ResearchCognitive Functions and Memory

Cited by 640

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease

Wattmo, C., Blennow, K., & Hansson, O. (2020) · BMC Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 93

Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting

Wallin, Å. K., Andreasen, N., Eriksson, S., Båtsman, S., Näsman, B., Ekdahl, A., Kilander, L., Grut, M., Rydén, M., Wallin, A., et al. (2007) · Dementia and Geriatric Cognitive Disorders

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 84

Mild versus moderate stages of Alzheimer’s disease: Three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

Wattmo, C., Minthon, L., & Wallin, Å. K. (2016) · Alzheimer's Research & Therapy

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 83

Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment

Wattmo, C., Wallin, Å. K., Londos, E., & Minthon, L. (2011) · Alzheimer Disease & Associated Disorders

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 52

Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting

Wallin, Å., Minthon, & Wattmo, C. (2011) · Neuropsychiatric Disease and Treatment

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 50

Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy

Wallin, Å. K., Gustafson, L., Sjögren, M., Wattmo, C., & Minthon, L. (2004) · Dementia and Geriatric Cognitive Disorders

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 45